45 related articles for article (PubMed ID: 20874822)
1. Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
Libé R; Pais A; Violon F; Guignat L; Bonnet F; Huillard O; Assié G; Gaillard M; Dousset B; Gaujoux S; Barat M; Dohan A; Sibony M; Bertherat J; Cottereau AS; Tenenbaum F; Coste J; Groussin L
Clin Nucl Med; 2023 May; 48(5):381-386. PubMed ID: 36758555
[TBL] [Abstract][Full Text] [Related]
2. Enterovesical Fistula in a Lymphoma Patient Revealed by FDG PET/CT With an Oral Contrast Agents.
Guo L; Shen G
Clin Nucl Med; 2024 Jan; 49(1):e38-e39. PubMed ID: 37976526
[TBL] [Abstract][Full Text] [Related]
3. Recent advancements in
Jamalipour Soufi G; Hekmatnia A; Hekmatnia F; Zarei AP; Shafieyoon S; Azizollahi S; Ghazanfari Hashemi M; Riahi F
Am J Nucl Med Mol Imaging; 2024; 14(2):97-109. PubMed ID: 38737646
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Radiological and Histopathological Evaluation of Primary Colon Lymphoma.
Tazeoglu D; Esmer AC; Colak T
Arch Iran Med; 2023 Jul; 26(7):370-373. PubMed ID: 38301095
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Human Brain Imaging with a Portable PET Camera: Comparison to a Standard Scanner.
Bartlett EA; Lesanpezeshki M; Anishchenko S; Shkolnik I; Ogden RT; Mann JJ; Beylin D; Miller JM; Zanderigo F
J Nucl Med; 2024 Feb; 65(2):320-326. PubMed ID: 38124218
[TBL] [Abstract][Full Text] [Related]
6. Is System x
Sharkey AR; Witney TH; Cook GJR
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067277
[TBL] [Abstract][Full Text] [Related]
7. Initial evaluation of (4S)-4-(3-[
Park SY; Mosci C; Kumar M; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Chin FT; Gambhir SS; Mittra ES
EJNMMI Res; 2020 Aug; 10(1):100. PubMed ID: 32857284
[TBL] [Abstract][Full Text] [Related]
8. T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.
Park HS; McIntosh L; Braschi-Amirfarzan M; Shinagare AB; Krajewski KM
Korean J Radiol; 2017; 18(1):71-83. PubMed ID: 28096719
[TBL] [Abstract][Full Text] [Related]
9. Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.
Huang H; Xiao F; Han X; Zhong L; Zhong H; Xu L; Zhu J; Ni B; Liu J; Fang Y; Zhang M; Shen L; Wang T; Liu J; Shi Y; Chen Y; Zheng L; Liu Q; Chen F; Wang J
Nucl Med Commun; 2016 Jul; 37(7):689-98. PubMed ID: 27244584
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.
Deng SM; Zhang W; Zhang B; Chen YY; Li JH; Wu YW
PLoS One; 2015; 10(6):e0129028. PubMed ID: 26038827
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.
Saito M; Miyazaki M; Tanino M; Tanaka S; Miyashita K; Izumiyama K; Mori A; Irie T; Tanaka M; Morioka M; Tsukamoto E
World J Gastroenterol; 2014 May; 20(17):5141-6. PubMed ID: 24803832
[TBL] [Abstract][Full Text] [Related]
12. Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma.
Wu X; Pertovaara H; Korkola P; Dastidar P; Järvenpää R; Eskola H; Kellokumpu-Lehtinen PL
PLoS One; 2014; 9(1):e84999. PubMed ID: 24454777
[TBL] [Abstract][Full Text] [Related]
13. Current status of PET/CT in the diagnosis and follow up of lymphomas.
Buchpiguel CA
Rev Bras Hematol Hemoter; 2011; 33(2):140-7. PubMed ID: 23284262
[TBL] [Abstract][Full Text] [Related]
14. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T
Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388
[TBL] [Abstract][Full Text] [Related]
15. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
Dierickx D; Tousseyn T; Requilé A; Verscuren R; Sagaert X; Morscio J; Wlodarska I; Herreman A; Kuypers D; Van Cleemput J; Nevens F; Dupont L; Uyttebroeck A; Pirenne J; De Wolf-Peeters C; Verhoef G; Brepoels L; Gheysens O
Haematologica; 2013 May; 98(5):771-5. PubMed ID: 23065524
[TBL] [Abstract][Full Text] [Related]
16. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Koranda P; Raida L; Kubová Z; Palová M; Kučerová L; Flodr P; Jarkovský J; Dušek L; Indrák K
Eur J Haematol; 2011 Jan; 86(1):32-7. PubMed ID: 20874822
[TBL] [Abstract][Full Text] [Related]
17. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H
Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
[TBL] [Abstract][Full Text] [Related]
18. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma.
Chang CC; Cho SF; Chen YW; Tu HP; Lin CY; Chang CS
Clin Nucl Med; 2012 Aug; 37(8):e189-95. PubMed ID: 22785526
[TBL] [Abstract][Full Text] [Related]
19. Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Lee H; Kim SK; Kim YI; Kim TS; Kang SH; Park WS; Yun T; Eom HS
J Nucl Med; 2014 Feb; 55(2):216-22. PubMed ID: 24365650
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
